MA

MOHD ABDULLAHA

University at Buffalo, State University of New York, Texas A&M University, AcsIR, Baylor College of Medicine

Research areas: Chemistry · Organic Chemistry · Synthesis and biological activity · Inflammasome and immune disorders · Cholinesterase and Neurodegenerative Diseases

ORCID iD 0000-0003-4875-7080

About

Dr. Mohd Abdullaha is a medicinal chemist and postdoctoral researcher in the Department of Chemistry at the University at Buffalo, The State University of New York. His research focuses on the rational design, synthesis, and biological evaluation of small-molecule therapeutics for cancer, neurodegenerative diseases, and viral infections through an interdisciplinary approach integrating medicinal chemistry, chemical biology, molecular modeling, and drug discovery.

During his Ph.D., Dr. Abdullaha worked on the development of multi-target-directed ligands for Alzheimer's disease, with a particular emphasis on cholinesterase inhibition and modulation of the NLRP3 inflammasome. His subsequent postdoctoral research expanded to antiviral drug discovery, including the development of inhibitors targeting the SARS-CoV-2 main protease (Mpro) and papain-like protease (PLpro), as well as targeted protein degradation strategies using PROTAC technology. He also contributed to the design of cyclic organopeptides and CDK-targeting degraders.

His current research is focused on discovering first-in-class small molecules that target TFE3 fusion oncoproteins in translocation renal cell carcinoma (tRCC). His work combines structure-based drug design, synthetic medicinal chemistry, computational modeling, biophysical and cellular assays, and in vivo efficacy studies to identify novel therapeutic strategies for cancers driven by oncogenic transcription factors.

Dr. Abdullaha has authored peer-reviewed publications and book chapters and serves as a reviewer for leading journals in medicinal chemistry and drug discovery. His long-term research goal is to translate innovative chemical approaches into effective therapies for diseases with significant unmet medical needs.

Employment

Education

  • AcsIR Ph.D
    2016 - 2021

Projects & Funding

Projects & funding information is unavailable.

Publications (12)